سويسرا - الفرنسية - Swissmedic (Swiss Agency for Therapeutic Products)

gsk consumer healthcare schweiz ag - metixeni hydrochloridum, du pancréas, de la poudre, cellulasum, pepsini la poussière, dimeticonum, natrii dehydrocholas, acidi glutamici hydrochloridum - bitabs - metixeni hydrochloridum 1 mg, du pancréas, de la poussière corresp. amylasum 2100 u. tél. eur. et lipasum 1200 u. tél. eur. et proteasum 80 u. tél. eur., cellulasum de 0,9 u. fip, pepsini poussière 120 u. tél. eur., dimeticonum 40 mg, natrii dehydrocholas 20 mg, acidi glutamici hydrochloridum 100 mg, color.: e 127, excipiens pro compresso. - de troubles de la digestion avec darmspasmen - synthetika

سويسرا - الفرنسية - Swissmedic (Swiss Agency for Therapeutic Products)

ebi-pharm ag - argentum nitricum (hab) d6, belladonna (ph.eur.hom.) d10 (ph.eur.hom. 1.1.3), bacterium coli d28 (hab 44), ceanothus americanus (hab) d4, psychotria ipecacuanha (hab) d8, hydrastis canadensis (ph.eur.hom.) d4 (ph.eur.hom. 1.1.8), kalium bichromicum (hab) d8, kreosotum (hab) d10, lachesis (hab) d10, mandragora e radice siccata (hab) d10, marsdenia cundurango (hab) d6, momordica balsamina (hab) d6, mucosa coli suis d8 (hab 42a), mucosa ductus choledochi suis d8 (hab 42a), mucosa duodeni suis d8 (hab 42a), mucosa ilei suis d8 (hab 42a), mucosa jejuni suis d8 (hab 42a), mucosa nasalis suis d8 (hab 42a), mucosa oculi suis d8 (hab 42a), mucosa oesophagi suis d8 (hab 42a), mucosa oris suis d8 (hab 42a), mucosa pulmonis suis d8 (hab 42a), mucosa pylori suis d8 (hab 42a), mucosa recti suis d8 (hab 42a), mucosa vesicae felleae suis d8 (hab 42a), mucosa vesicae urinariae suis d8 (hab 42a), natrium diethyloxalaceticum d8 (hab 6), oxalis acetosella (hab) d6, pancreas suis d10 (hab 42a), phosphorus (hab) d8, pulsatilla pratensis (hab) d6, anacardium (ph.eur.hom.) d6, nux-vomica (ph.eur.hom.) d13 (ph.eur.hom. 1.1.8), sulfur (hab) d8, ventriculus suis d8 (hab 42a), veratrum album (hab) d4 - injektionslösung (i.m., s.c.) - argentum nitricum (hab) d6 22.0 mg, belladonna (ph.eur.hom) d10 (ph.eur.hom. 1.1.3) 22.0 mg, bacterium coli d28 (hab 44) 22.0 mg, ceanothus americanus (hab) d4 22.0 mg, psychotria ipecacuanha (hab) d8 22.0 mg, hydrastis canadensis (ph.eur.hom.) d4 (ph.eur.hom. 1.1.8) 22.0 mg, kalium bichromicum (hab) d8 22.0 mg, kreosotum (hab) d10 22.0 mg, lachesis (hab) d10 22.0 mg, mandragora e radice siccata (hab) d10 22.0 mg, marsdenia cundurango (hab) d6 22.0 mg, momordica balsamina (hab) d6 22.0 mg, mucosa coli suis d8 (hab 42a) 22.0 mg, mucosa ductus choledochi suis d8 (hab 42a) 22.0 mg, mucosa duodeni suis d8 (hab 42a) 22.0 mg, mucosa ilei suis d8 (hab 42a) 22.0 mg, mucosa jejuni suis d8 (hab 42a) 22.0 mg, mucosa nasalis suis d8 (hab 42a) 22.0 mg, mucosa oculi suis d8 (hab 42a) 22.0 mg, mucosa oesophagi suis d8 (hab 42a) 22.0 mg, mucosa oris suis d8 (hab 42a) 22.0 mg, mucosa pulmonis suis d8 (hab 42a) 22.0 mg, mucosa pylori suis d8 (hab 42a) 22.0 mg, mucosa recti suis d8 (hab 42a) 22.0 mg, mucosa vesicae felleae suis d8 (hab 42a) 22.0 mg, mucosa vesicae urinariae suis d8 (hab 42a) 22.0 mg, natrium diethyloxalaceticum d8 (hab 6) 22.0 mg, oxalis acetosella (hab) d6 22.0 mg, pancreas suis d10 (hab 42a) 22.0 mg, phosphorus (hab) d8 22.0 mg, pulsatilla pratensis (hab) d6 22.0 mg, anacardium (ph.eur.hom.) d6 22.0 mg, nux-vomica (ph.eur.hom.) d13 (ph.eur.hom. 1.1.8) 22.0 mg, sulfur (hab) d8 22.0 mg, ventriculus suis d8 (hab 42a) 22.0 mg, veratrum album (hab) d4 22.0 mg, aqua ad iniectabilia, natrii chloridum corresp. natrium 7.52 mg, ad solutionem pro 2.2 ml. - sans indication, - les médicaments homéopathiques

سويسرا - الفرنسية - Swissmedic (Swiss Agency for Therapeutic Products)

ebi-pharm ag - argentum nitricum (hab) d6, atropa bella-donna (hab) d10 (ph.eur.hom. 1.1.3), ceanothus americanus (hab) d4, hydrastis canadensis (ph.eur.hom.) d6 (ph.eur.hom. 1.1.8), kalium bichromicum (hab) d8, kreosotum (hab) d12, lachesis (hab) d10 (hab sv), mandragora (ph.eur.hom.) d10 (ph.eur.hom. 1.1.8), marsdenia cundurango (hab) d6, momordica balsamina (hab) d6, mucosa coli suis d8 (hab 42a), mucosa ductus choledochi suis d8 (hab 42a), mucosa duodeni suis d8 (hab 42a), mucosa ilei suis d8 (hab 42a), mucosa jejuni suis d8 (hab 42a), mucosa nasalis suis d8 (hab 42a), mucosa oculi suis d8 (hab 42a), mucosa oesophagi suis d8 (hab 42a), mucosa oris suis d8 (hab 42a), mucosa pulmonis suis d8 (hab 42a), mucosa pylori suis d8 (hab 42a), mucosa recti suis d8 (hab 42a), mucosa vesicae felleae suis d8 (hab 42a), mucosa vesicae urinariae suis d8 (hab 42a), oxalis acetosella (hab) d6, pancreas suis d10 (hab 42a), phosphorus (hab) d8 (hab sv), pulsatilla pratensis (hab) d6, psychotria ipecacuanha (hab) d8, semecarpus anacardium (hab) d6, strychnos nux-vomica (hab) d13 (ph.eur.hom. 1.1.8), sulfur (hab) d8 (hab sv), ventriculus suis d8 (hab 42a), veratrum album (hab) d6 - comprimés - argentum nitricum (hab) d6 1.0 mg, atropa bella-donna (hab) d10 (ph.eur.hom. 1.1.3) 1.0 mg, ceanothus americanus (hab) d4 1.0 mg, hydrastis canadensis (ph.eur.hom.) d6 (ph.eur.hom. 1.1.8) 1.0 mg, kalium bichromicum (hab) d8 1.0 mg, kreosotum (hab) d12 1.0 mg, lachesis (hab) d10 (hab sv) 1.0 mg, mandragora (ph.eur.hom.) d10 (ph.eur.hom. 1.1.8) 1.0 mg, marsdenia cundurango (hab) d6 1.0 mg, momordica balsamina (hab) d6 1.0 mg, mucosa coli suis d8 (hab 42a) 1.0 mg, mucosa ductus choledochi suis d8 (hab 42a) 1.0 mg, mucosa duodeni suis d8 (hab 42a) 1.0 mg, mucosa ilei suis d8 (hab 42a) 1.0 mg, mucosa jejuni suis d8 (hab 42a) 1.0 mg, mucosa nasalis suis d8 (hab 42a) 1.0 mg, mucosa oculi suis d8 (hab 42a) 1.0 mg, mucosa oesophagi suis d8 (hab 42a) 1.0 mg, mucosa oris suis d8 (hab 42a) 1.0 mg, mucosa pulmonis suis d8 (hab 42a) 1.0 mg, mucosa pylori suis d8 (hab 42a) 1.0 mg, mucosa recti suis d8 (hab 42a) 1.0 mg, mucosa vesicae felleae suis d8 (hab 42a) 1.0 mg, mucosa vesicae urinariae suis d8 (hab 42a) 1.0 mg, oxalis acetosella (hab) d6 1.0 mg, pancreas suis d10 (hab 42a) 1.0 mg, phosphorus (hab) d8 (hab sv) 1.0 mg, pulsatilla pratensis (hab) d6 1.0 mg, psychotria ipecacuanha (hab) d8 1.0 mg, semecarpus anacardium (hab) d6 1.0 mg, strychnos nux-vomica (hab) d13 (ph.eur.hom. 1.1.8) 1.0 mg, sulfur (hab) d8 (hab sv) 1.0 mg, ventriculus suis d8 (hab 42a) 1.0 mg, veratrum album (hab) d6 1.0 mg, lactosum monohydricum 300 mg, magnesii stearas, pro compresso 301.5 mg. - zulassung mit reduziertem dossier ohne indikation nach art. 25 abs. 1 kpav (sr 812.212.24) - les médicaments homéopathiques

سويسرا - الفرنسية - Swissmedic (Swiss Agency for Therapeutic Products)

ebi-pharm ag - acidum alpha-ketoglutaricum d10 (hab 5a), acidum thiocticum d8 (hab 6), acidum malicum d10 (hab 5a), acidum fumaricum d10 (hab 5a), acidum oroticum monohydricum d6 (hab 6), avena sativa (hab) d6, calcium carbonicum hahnemanni (hab) d28, chelidonium majus (hab) d4, cholesterolum (hab) d10, cinchona pubescens (hab) d4, cyanocobalaminum d4 (hab 5a), colon suis d10 (hab 42a), cynara scolymus ex herba d6 (hab 3a), duodenum suis d10 (hab 42a), fel tauri d8 (hab 5a), hepar suis d8 (hab 42a), histaminum d10 (hab 5a), lycopodium clavatum (hab) d4, natrium diethyloxalaceticum d10 (hab 6), pancreas suis d10 (hab 42a), silybum marianum (hab) d3, sulfur (hab) d13, taraxacum officinale (hab) d4, thymus suis d10 (hab 42a), veratrum album (hab) d4, vesica fellea suis d10 (hab 42a) - solution injectable (s. c. i. m.) - acidum alpha-ketoglutaricum d10 (hab 5a) 22.0 mg, acidum thiocticum d8 (hab 6) 22.0 mg, acidum malicum d10 (hab 5a) 22.0 mg, acidum fumaricum d10 (hab 5a) 22.0 mg, acidum oroticum monohydricum d6 (hab 6) 22.0 mg, avena sativa (hab) d6 22.0 mg, calcium carbonicum hahnemanni (hab) d28 22.0 mg, chelidonium majus (hab) d4 22.0 mg, cholesterolum (hab) d10 22.0 mg, cinchona pubescens (hab) d4 22.0 mg, cyanocobalaminum d4 (hab 5a) 22.0 mg, colon suis d10 (hab 42a) 22.0 mg, cynara scolymus ex herba d6 (hab 3a) 22.0 mg, duodenum suis d10 (hab 42a) 22.0 mg, fel tauri d8 (hab 5a) 22.0 mg, hepar suis d8 (hab 42a) 22.0 mg, histaminum d10 (hab 5a) 22.0 mg, lycopodium clavatum (hab) d4 22.0 mg, natrium diethyloxalaceticum d10 (hab 6) 22.0 mg, pancreas suis d10 (hab 42a) 22.0 mg, silybum marianum (hab) d3 22.0 mg, sulfur (hab) d13 22.0 mg, taraxacum officinale (hab) d4 22.0 mg, thymus suis d10 (hab 42a) 22.0 mg, veratrum album (hab) d4 22.0 mg, vesica fellea suis d10 (hab 42a) 22.0 mg, natrii chloridum, aqua ad iniectabilia, pro vitro 2.2 ml corresp. natrium 7.64 mg. - zulassung mit reduziertem dossier ohne indikation nach art. 25 abs. 1 kpav (sr 812.212.24) - les médicaments homéopathiques

سويسرا - الفرنسية - Swissmedic (Swiss Agency for Therapeutic Products)

wala schweiz ag - cor bovis gl d5 (hab 41c), hepar bovis gl d5 (hab 41a), mesenchym bovis gl d5 (hab 41b), pancreas suis gl d5 (hab 41a), pulmo bovis gl d5 (hab 41a), quercus robur/petraea e cortice cum calcio carbonico d12 (hab 5b) (factus ex: quercus robur/petraea e cortice, decoctum tm (hab 23a) potentiae cum calcium carbonicum e cinere quercus corticis solutum), renes bovis gl d5 (hab 41a) - solution injectable (s. c.) - cor bovis gl d5 (hab 41c) 100 mg, hepar bovis gl d5 (hab 41a) 100 mg, mesenchym bovis gl d5 (hab 41b) 100 mg, pancreas suis gl d5 (hab 41a) 100 mg, pulmo bovis gl d5 (hab 41a) 100 mg, quercus robur/petraea e cortice cum calcio carbonico d12 (hab 5b) (factus ex: quercus robur/petraea e cortice, decoctum tm (hab 23a) potentiae cum calcium carbonicum e cinere quercus corticis solutum) 100 mg, renes bovis gl d5 (hab 41a) 100 mg, natrii chloridum, natrii hydrogenocarbonas, aqua ad iniectabile, pro vitro 1 ml corresp. natrium 3.5 mg. - zulassung mit reduziertem dossier ohne indikation nach art. 25 abs. 1 kpav (sr 812.212.24) - médicaments anthroposophiques

كندا - الفرنسية - Health Canada

bio active canada ltd. - carbonate de baryum; cobalt; ginkgo biloba; nickel; pancréas; acide phosphorique; phosphore; zinc - liquide - 12x; 8x; 6x; 8x; 8x; 12x; 12x; 8x - carbonate de baryum 12x; cobalt 8x; ginkgo biloba 6x; nickel 8x; pancréas 8x; acide phosphorique 12x; phosphore 12x; zinc 8x - homeopathic products

كندا - الفرنسية - Health Canada

bio active canada ltd. - cuivre; ginkgo biloba; pancréas; zinc - liquide - 8x; 6x; 8x; 8x - cuivre 8x; ginkgo biloba 6x; pancréas 8x; zinc 8x - homeopathic products

سويسرا - الفرنسية - Swissmedic (Swiss Agency for Therapeutic Products)

sérolab, société anonyme - globulina equina (immunisé avec muqueuse duodénal, pancréas, vésicule biliaire et foie de porcins) - suppositoire - globulina equina (immunisé avec muqueuse duodénal, pancréas, vésicule biliaire et foie de porcins) 8 mg, propylenglycolum, conserv.: propylis parahydroxybenzoas, e 218, excipiens pro suppositorio. - traitement immunomodulant selon le dr thomas; possibilités d'emploi voir information professionnelle - d'autres komplementärarzneimittel

الاتحاد الأوروبي - الفرنسية - EMA (European Medicines Agency)

nova laboratories ireland limited - azathioprine - rejet de greffe - immunosuppresseurs - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.

بلجيكا - الفرنسية - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

heel belgium sa-nv - avena sativa 22 mg; calcium carbonicum hahnemani 22 mg; silybum marianum 22 mg; chelidonium majus 22 mg; cinchona pubescens 22 mg; colon suis 22 mg; cyanocobalaminum 22 mg; cynara scolymus 22 mg; fumaricum acidum 22 mg; hepar suis 22 mg; histaminum 22 mg; acidum alpha-ketoglutaricum 22 mg; lycopodium clavatum 22 mg; malicum acidum 22 mg; natrium diethyloxalaceticum 22 mg; soufre 22 mg; taraxacum officinale 22 mg; acide thioctique 22 mg; thymus suis 22 mg; veratrum album 22 mg; vesicae fellea suis 22 mg; duodenum suis 22 mg; pancreas suis 22 mg - solution injectable